Four COVID-19 vaccine candidates induce immune responses in preliminary studies, but questions remain
Wednesday, July 22, 2020 - 11:21
in Health & Medicine
CanSino, Moderna, Oxford, and Pfizer publish results from early clinical trials that show the vaccines may be safe and induce moderate antibody responses